It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
This article summarizes the recent activity of the International Stem Cell Banking Initiative (ISCBI) held at the California Institute for Regenerative Medicine (CIRM) in California (June 26, 2016) and the Korean National Institutes for Health in Korea (October 19–20, 2016). Through the workshops, ISCBI is endeavoring to support a new paradigm for human medicine using pluripotent stem cells (hPSC) for cell therapies. Priority considerations for ISCBI include ensuring the safety and efficacy of a final cell therapy product and quality assured source materials, such as stem cells and primary donor cells. To these ends, ISCBI aims to promote global harmonization on quality and safety control of stem cells for research and the development of starting materials for cell therapies, with regular workshops involving hPSC banking centers, biologists, and regulatory bodies. Here, we provide a brief overview of two such recent activities, with summaries of key issues raised. S
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details


1 Korea Stem Cell Bank, Center for Biomedical Sciences, Korea National Institute of Health (KNIH), Osong, South Korea
2 Charité Universitätsmedizin Berlin, Berlin, Germany
3 Cell Collection and Research Center, National Institutes for Food and Drug Control, Beijing, China
4 Shanghai Institute of Medical Genetics, Shanghai Jiao Tong University, Shanghai, China
5 California Institute for Regenerative Medicine, Oakland, CA, USA
6 Department of Molecular Medicine Center for Regenerative Medicine The Scripps Research Institute, San Diego, CA, USA
7 ARC Centre of Excellence for Electromaterials Science, Intelligent Polymer Research Institute, AIIM Facility, University of Wollongong, Fairy Meadow, New South Wales, Australia; Illawarra Health and Medical Research Institute, University of Wollongong, Wollongong, New South Wales, Australia; Department of Surgery, St. Vincent's Hospital, The University of Melbourne, Fitzroy, Victoria, Australia
8 Catholic University, Seoul, Korea
9 European Molecular Biology Laboratory, European Bioinformatics Institute, Wellcome Genome Campus, Hinxton, Cambridge, UK
10 Molecular Biology and Genetics Unit, Jawaharlal Nehru Centre for Advanced Scientific Research, Bangalore, India
11 Jackson Laboratories, Bar Harbor, ME, USA
12 Stem Cell Institute and Department of Medicine, University of Minnesota, Minneapolis, MN, USA
13 Department of Genetics, Rutgers, The State University of New Jersey, Piscataway, NJ
14 University of Toronto, Toronto, Ontario, Canada
15 UK Stem Cell Bank, Division of Advanced Therapies, NIBSC, South Mimms, UK
16 Stem Cell Research Institute, Federal University of Rio Grande do Sul, Porto Alegre, Brazil
17 Institute of Zoology, Chinese Academy of Sciences, Beijing, China
18 Department of Human Genetics, University of Miami Miller School of Medicine, Miami, FL, USA
19 Department of Obstetrics and Gynecology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand
20 Foundation for Biomedical Research and Innovation, Kobe, Japan
21 Stem Cell Group, Bioprocessing Technology Institute, A*STAR, Singapore
22 WiCell Research Institute, Madison, WI, USA
23 Keio University/SKIP, Yokahama, Japan
24 Cellular Dynamics International, Madison, WI, USA
25 University of Kyoto, Kyoto, Japan
26 Department of Cell Growth and Differentiation, Center for iPS Cell Research and Application, Kyoto University, Kyoto, Japan